Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
Eli Lilly to invest $700M to enhance global insulin manufacturing capacity
Yahoo/Fly on the Wall
Thu, 11/14/13 - 10:29 am
Eli Lilly
drug manufacturing
insulin
diabetes
Pfizer, Lilly Vs. Rivals In Potential Pain Drug Rivalry
Seeking Alpha
Wed, 11/13/13 - 08:32 am
Pfizer
Eli Lilly
painkillers
tanezumab
Eli Lilly’s Lackluster Pipeline + Premium Valuation = Goldman Sachs Downgrade
Barron's
Mon, 11/11/13 - 02:19 pm
Eli Lilly
Eli Lilly Goes Down The Hill As Patents Expire
Seeking Alpha
Sat, 11/9/13 - 12:33 pm
Eli Lilly
patents
Novo Nordisk And The Danish Delusion
Forbes
Fri, 11/8/13 - 10:50 am
Novo Nordisk
Denmark
Eli Lilly
diabetes
insulin
Analyst ranks the top 11 pharma giants' prospects, putting GSK on top
Fierce Biotech
Wed, 11/6/13 - 10:39 am
GSK
Bayer
Sanofi
Novartis
JNJ
Bristol-Myers Squibb
Merck
AbbVie
Eli Lilly
Pfizer
AstraZeneca
Testosterone Drugs Raise Heart Risk in $1 Billion Market
Bloomberg
Wed, 11/6/13 - 08:34 am
testosterone
Eli Lilly
Actavis
Androgel
Axiron
AbbVie
Androderm
We Like What We're Seeing In Big Pharma
Seeking Alpha
Tue, 11/5/13 - 08:42 am
Bristol-Myers Squibb
AbbVie
Eli Lilly
Ex-Lilly contract sales rep sues, claiming unpaid bonuses
Fierce Pharma
Mon, 11/4/13 - 04:39 pm
Eli Lilly
contract reps
3 Blockbuster Drugs Losing Patent Protection in 2013's Final Months
Motley Fool
Fri, 11/1/13 - 08:38 am
patents
Amgen
Neupogen
Merck KGaA
Rebif
Cymbalta
Eli Lilly
Eli Lilly: Cymbalta Patent Expiry Quantified
Seeking Alpha
Mon, 10/28/13 - 03:33 pm
patents
Eli Lilly
Cymbalta
Pfizer
Merck
antidepressants
Top 10 Drug Patent Losses of 2014
Fierce Pharma
Mon, 10/28/13 - 10:26 am
patents
Copaxone
Teva
Nexium
AstraZeneca
Micardis
Boehringer Ingelheim
Sandostatin LAR
Novartis
Exforge
Nasonex
Merck
TriLipix
AbbVie
Evista
Eli Lilly
Restasis
Allergan
Renagel
Sanofi
Q3 Earnings Roundup for Pharmaceutical Stocks
InvestorPlace
Fri, 10/25/13 - 11:37 am
earnings
Amgen
Eli Lilly
Bristol-Myers Squibb
FDA Grants Lilly's Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer
Marketwatch
Thu, 10/24/13 - 10:29 am
FDA
ramucirumab
Eli Lilly
gastric cancer
Lilly Beats Analyst Estimates on Diabetes Drug Sales
Bloomberg
Wed, 10/23/13 - 08:41 am
Eli Lilly
earnings
Lilly's Pipeline Fears Are Overblown
TheStreet.com
Tue, 10/22/13 - 08:14 am
Eli Lilly
Merck
Pfizer
patent cliff
Lilly's Lechleiter isn't budging from stand-alone $5B R&D strategy--yet
Fierce Biotech
Mon, 10/21/13 - 11:55 am
John Lechleiter
R&D
Eli Lilly
Can Eli Lilly Earnings Keep Up With Merck and Pfizer?
Motley Fool
Mon, 10/21/13 - 11:52 am
Eli Lilly
earnings
Merck
Pfizer
Universities Stepping Up Efforts To Discover Drugs
Forbes
Mon, 10/21/13 - 09:32 am
R&D
Eli Lilly
Academic Drug Discovery Consortium
ADDC
Pfizer: The Menopause Opportunity
Seeking Alpha
Fri, 10/18/13 - 06:19 pm
Pfizer
Duavee
menopause
Ligand Pharmaceuticals
Eli Lilly
Hisamitsu
hot flashes
Pages
« first
‹ previous
…
92
93
94
95
96
97
98
99
100
…
next ›
last »